Portosystemic shunt surgery in patients with idiopathic noncirrhotic portal hypertension

Basit Öğe Kaydı
dc.authorscopusid37037560900
dc.authorscopusid34881191200
dc.authorscopusid37089800900
dc.authorscopusid56647910700
dc.authorscopusid56647985900
dc.authorscopusid57217650998
dc.authorscopusid8378959500
dc.contributor.authorKaragul S.
dc.contributor.authorYagci M.A.
dc.contributor.authorTardu A.
dc.contributor.authorErtugrul I.
dc.contributor.authorKirmizi S.
dc.contributor.authorSumer F.
dc.contributor.authorIsik B.
dc.date.accessioned2024-08-04T20:02:22Z
dc.date.available2024-08-04T20:02:22Z
dc.date.issued2016
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: Idiopathic noncirrhotic portal hypertension (INCPH) is a rare disease characterized by increased portal venous pressure in the absence of cirrhosis and other causes of liver diseases. The aim of the present study was to present our results in using portosystemic shunt surgery in patients with INCPH. Material/Methods: Patients who had been referred to our Liver Transplantation Institute for liver transplantation and who had undergone surgery from January 2010 to December 2015 were retrospectively analyzed. Patients with INCPH who had undergone portosystemic shunt procedure were included in the study. Age, sex, symptoms and findings, type of portosystemic shunt, and postoperative complications were assessed. Results: A total of 1307 patients underwent liver transplantation from January 2010 to December 2015. Eleven patients with INCPH who did not require liver transplantation were successfully operated on with a portosystemic shunt procedure. The mean follow-up was 30.1±19 months (range 7–69 months). There was no mortality in the perioperative period or during the follow-up. Two patients underwent surgery again due to intra-abdominal hemorrhage; one had bleeding from the surgical site except the portacaval anastomosis and the other had bleeding from the h-graft anastomosis. No patient developed encephalopathy and no patient presented with esophageal variceal bleeding after portosystemic shunt surgery. Shunt thrombosis occurred in 1 patient (9.9%). Only 1 patient developed ascites, which was controlled medically. Conclusions: Portosystemic shunt surgery is a safe and effective procedure for the treatment of patients with INCPH. © Ann Transplant, 2016.en_US
dc.identifier.doi10.12659/AOT.898253
dc.identifier.endpage320en_US
dc.identifier.issn1425-9524
dc.identifier.pmid27194018en_US
dc.identifier.scopus2-s2.0-84970044293en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage317en_US
dc.identifier.urihttps://doi.org/10.12659/AOT.898253
dc.identifier.urihttps://hdl.handle.net/11616/91636
dc.identifier.volume21en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherMedical Science Internationalen_US
dc.relation.ispartofAnnals of Transplantationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAscitesen_US
dc.subjectGastrointestinal hemorrhageen_US
dc.subjectHypertension, portalen_US
dc.subjectLiver transplantationen_US
dc.subjectPortasystemic shunt, surgicalen_US
dc.subjectSplenorenal shunt, surgicalen_US
dc.titlePortosystemic shunt surgery in patients with idiopathic noncirrhotic portal hypertensionen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu